Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

98 Derivation and Validation of a Pharmacogenetic-guided Warfarin Dosing Algorithm in an Arab Population Residing in Qatar

Type de record:

paper
Créateur:
AmrAhmMohMoh
Éditeur:
Elsevier BV
Hôte:

Visit

doi.org

Licenses

https://www.elsevier.com/tdm/userlicense/1.0/https://www.elsevier.com/legal/tdmrep-licensehttp://creativecommons.org/licenses/by-nc-nd/4.0/

Similaires

Warfarin pharmacogenetics: development of a dosing algorithm for Omani patientsDataset for "Limited transportability of published acenocoumarol dosing algorithms in an Algerian pharmacogenetic cohort"Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose–initiation algorithmMapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented PopulationPharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African populationmjc2244/Uganda-Sepsis-Endotype-Derivation-and-Validation

Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients

International audience The objective of our present study was to develop a warfarin d

Dataset for "Limited transportability of published acenocoumarol dosing algorithms in an Algerian pharmacogenetic cohort"

De-identified participant-level dataset supporting the article “Limited transportability of publishe

Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose–initiation algorithm

Abstract Warfarin remains the most widely prescribed oral anticoagulant in sub‐Saharan Africa. Howe

Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population

Africans are extremely underrepresented in global genomic research. African populations face high bu

Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population

Abstract Background Dolutegravir has been a

mjc2244/Uganda-Sepsis-Endotype-Derivation-and-Validation

R code for derivation, validation, differential expression and enrichment analyses of transcriptomic